|
Dear colleague,
This email updates you on details of recently published MHRA guidance on the coronavirus (COVID-19) pandemic aimed at supporting healthcare partners.
How tests and testing kits for COVID-19 work
The guidance has information on the different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
We have re-written the guidance 'For patients, the public and professional users: a guide to COVID-19 tests and testing kits' to make it clearer how the different types of tests work, and who can use them.
CPRD data during COVID-19
Clinical Practice Research Datalink (CPRD), an MHRA centre, is making COVID-19 research a top priority, by fast-tracking protocols for COVID-19 research. All approved study protocol summaries are published within 72 hours, to ensure transparency and to help avoid unnecessary duplication. Please check the list of studies for regular updates.
Guidance for industry
We continue to update our guidance page for industry on GOV.UK as our response to COVID-19 evolves.
Subscribing to updates on GOV.UK
You can sign up for email updates about the MHRA’s work – you will then receive an email every time the MHRA publishes a new page or makes a significant edit to an existing page.
Contacting the MHRA
Most of our workforce is working from home, although National Institute for Biological Standards and Control (NIBSC) is continuing essential laboratory activities on site. If you need to get in touch with the MHRA during this period, please email or phone us.
For more information please visit mhra.gov.uk.
We welcome your feedback on what other information you would find useful – please email engagement@mhra.gov.uk.
Kind regards,
Patient, Public and Stakeholder Engagement team
Communications division
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone: 0203 080 6000
Email: engagement@mhra.gov.uk
gov.uk/mhra
Follow us on social media
Read our guidance on coronavirus (COVID-19)
|
